Pre-hospital rule-out of non-ST-segment elevation acute coronary syndrome by a single troponin: final one-year outcomes of the ARTICA randomised trial.
Goaris W A AartsCyril CamaroEddy M M AdangLaura RodwellRoger van HoutGijs BrokAnouk HoareFrank de PooterWalter de WitGilbert E CramerRoland R J van KimmenadeEva OuwendijkMartijn G S RuttenErwin ZegersRobert-Jan M van GeunsMarc E R GomesPeter DammanNiels van RoyenPublished in: European heart journal. Quality of care & clinical outcomes (2024)
Pre-hospital rule-out of NSTE-ACS with POC troponin testing in low-risk patients is cost-effective, as expressed by a sustainable healthcare cost reduction and no significant effect on QoL. One-year MACE remained low for both strategies.
Keyphrases
- acute coronary syndrome
- healthcare
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- antiplatelet therapy
- peritoneal dialysis
- adverse drug
- acute care
- clinical trial
- emergency department
- skeletal muscle
- metabolic syndrome
- study protocol
- open label
- type diabetes
- patient reported outcomes
- patient reported
- health insurance
- electronic health record
- drug induced